I

Incyte

Biopharmaceutical company pursuing drug discovery.

Field Access Director - Dermatology

Customer SuccessPosted on Nov 9
Full-timeUnited StatesNo salary listed

About the Job

Requirements

  • A bachelor's degree or equivalent experience is required; an advanced degree or clinical license is preferred.
  • Seven or more years of pharmaceutical or biotechnology experience and five or more years of reimbursement experience are preferred.
  • Three or more years leading a field reimbursement team is preferred, along with experience in retail and specialty pharmacy and dermatology.
  • Three years of experience in retail pharmacy and dermatology disease state are required.
  • At least three years of management experience are required.
  • Experience in dermatology coverage and competitive launches is preferred, including understanding of patients, providers, patient advocates, and healthcare providers.
  • Experience working with pharmacy distribution services and expertise in co-pay and patient access support programs are required.
  • Ability to identify key access and reimbursement barriers to treatment and design effective resolution plans is required.
  • Ability to work independently and in a cross-functional team environment is required.
  • Strong clinical knowledge related to payer approval processes and solid business acumen are required.
  • Strong organizational, problem-solving, and project management skills are required.
  • Competence using Salesforce CRM, Microsoft Word, Excel, and PowerPoint is required.
  • Ability to travel within the United States, with accommodations as needed, up to 40% is required.

Responsibilities

  • Develop the overall Field Access Manager strategy and lead the field access manager team.
  • Recruit, onboard, lead, and empower Field Access Managers to support Opzelura and future dermatology launch products.
  • Foster a collaborative, inclusive, high-performing team culture that encourages accountability and innovation.
  • Provide regular performance feedback, coaching, and professional development to team members.
  • Partner with the Director of FAM Training to develop team training curriculum focused on proactive healthcare professional education, case management and compliance, access, distribution, affordability, and disease and product knowledge.
  • Serve as the escalation point for regional access and reimbursement challenges; monitor, analyze, and triage situations that may adversely affect patient access to therapy.
  • Serve as a subject matter expert on access and reimbursement networks for Incyte dermatology products.
  • Partner with the Executive Director of Patient Access to develop strategy, tactics, and messaging aligned with Market Access priorities, create key performance metrics, and develop business rules, standard operating procedures, and working norms.
  • Use analytics and reporting dashboards to identify regional access and reimbursement issues and collaborate with Sales, Marketing, and Market Access leadership on strategic solutions and action plans.
  • Conduct business in accordance with ethical, legal, and compliance standards, including completing required training on time.
  • Provide consistent guidance during team calls, field rides, and meeting engagements to ensure the team compliantly and effectively uses tools and materials to educate healthcare professionals.

Desired Qualifications

  • An advanced degree or clinical license is preferred.
  • Seven or more years of pharmaceutical or biotechnology experience and five or more years of reimbursement experience are preferred.
  • Three or more years leading a field reimbursement team, experience in retail and specialty pharmacy, and dermatology experience are preferred.
  • Experience in dermatology coverage and competitive launches is preferred.

About the Company

Incyte

Biopharmaceutical company pursuing drug discovery.

Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Wilmington, DE
Founded
1991

Recently Posted Jobs

Explore more opportunities at Incyte

See more jobs